163 related articles for article (PubMed ID: 34678728)
1. Development and biological evaluation of AzoBGNU: A novel hypoxia-activated DNA crosslinking prodrug with AGT-inhibitory activity.
Liu Q; Wang X; Li J; Wang J; Sun G; Zhang N; Ren T; Zhao L; Zhong R
Biomed Pharmacother; 2021 Dec; 144():112338. PubMed ID: 34678728
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and antitumor activity evaluation of a novel combi-nitrosourea prodrug: Designed to release a DNA cross-linking agent and an inhibitor of O(6)-alkylguanine-DNA alkyltransferase.
Sun G; Zhang N; Zhao L; Fan T; Zhang S; Zhong R
Bioorg Med Chem; 2016 May; 24(9):2097-107. PubMed ID: 27041398
[TBL] [Abstract][Full Text] [Related]
3. NBGNU: a hypoxia-activated tripartite combi-nitrosourea prodrug overcoming AGT-mediated chemoresistance.
Ge Y; Lai X; Li J; Yu R; Zhuang Z; Sun G; Cui X; Zhang N; Zhao L; Upadhyaya P; Zhong R
Future Med Chem; 2019 Feb; 11(4):269-284. PubMed ID: 30560688
[No Abstract] [Full Text] [Related]
4. Synthesis and Antitumor Activity Evaluation of a Novel Combi-nitrosourea Prodrug: BGCNU.
Wang Y; Ren T; Lai X; Sun G; Zhao L; Zhang N; Zhong R
ACS Med Chem Lett; 2017 Feb; 8(2):174-178. PubMed ID: 28197307
[TBL] [Abstract][Full Text] [Related]
5. Influence of the Expression Level of O6-Alkylguanine-DNA Alkyltransferase on the Formation of DNA Interstrand Crosslinks Induced by Chloroethylnitrosoureas in Cells: A Quantitation Using High-Performance Liquid Chromatography-Mass Spectrometry.
Li L; Li S; Sun G; Peng R; Zhao L; Zhong R
PLoS One; 2015; 10(3):e0121225. PubMed ID: 25799182
[TBL] [Abstract][Full Text] [Related]
6. Design of a hypoxia-activated prodrug inhibitor of O6-alkylguanine-DNA alkyltransferase.
Zhu R; Seow HA; Baumann RP; Ishiguro K; Penketh PG; Shyam K; Sartorelli AC
Bioorg Med Chem Lett; 2012 Oct; 22(19):6242-7. PubMed ID: 22932317
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of AGT-Mediated Repair of dG-dC Cross-Links in the Drug Resistance to Chloroethylnitrosoureas: Molecular Docking, MD Simulation, and ONIOM (QM/MM) Investigation.
Wang J; Ren T; Sun G; Zhang N; Zhao L; Zhong R
J Chem Inf Model; 2024 Apr; 64(8):3411-3429. PubMed ID: 38511939
[TBL] [Abstract][Full Text] [Related]
8. Investigations on the effect of O(6)-benzylguanine on the formation of dG-dC interstrand cross-links induced by chloroethylnitrosoureas in human glioma cells using stable isotope dilution high-performance liquid chromatography electrospray ionization tandem mass spectrometry.
Sun G; Zhao L; Fan T; Li S; Zhong R
Chem Res Toxicol; 2014 Jul; 27(7):1253-62. PubMed ID: 24914620
[TBL] [Abstract][Full Text] [Related]
9. 4-nitrobenzyloxycarbonyl derivatives of O(6)-benzylguanine as hypoxia-activated prodrug inhibitors of O(6)-alkylguanine-DNA alkyltransferase (AGT), which produces resistance to agents targeting the O-6 position of DNA guanine.
Zhu R; Liu MC; Luo MZ; Penketh PG; Baumann RP; Shyam K; Sartorelli AC
J Med Chem; 2011 Nov; 54(21):7720-8. PubMed ID: 21955333
[TBL] [Abstract][Full Text] [Related]
10. Glycolytic inhibition by 3-bromopyruvate increases the cytotoxic effects of chloroethylnitrosoureas to human glioma cells and the DNA interstrand cross-links formation.
Sun X; Sun G; Huang Y; Zhang S; Tang X; Zhang N; Zhao L; Zhong R; Peng Y
Toxicology; 2020 Apr; 435():152413. PubMed ID: 32109525
[TBL] [Abstract][Full Text] [Related]
11. Quantification of DNA interstrand crosslinks induced by ACNU in NIH/3T3 and L1210 cells using high-performance liquid chromatography/electrospray ionization tandem mass spectrometry.
Li L; Zhao L; Zhong R
Rapid Commun Mass Spectrom; 2014 Mar; 28(5):439-47. PubMed ID: 24497281
[TBL] [Abstract][Full Text] [Related]
12. KS900: A hypoxia-directed, reductively activated methylating antitumor prodrug that selectively ablates O(6)-alkylguanine-DNA alkyltransferase in neoplastic cells.
Baumann RP; Ishiguro K; Penketh PG; Shyam K; Zhu R; Sartorelli AC
Biochem Pharmacol; 2011 May; 81(10):1201-10. PubMed ID: 21396917
[TBL] [Abstract][Full Text] [Related]
13. Acridine-O
Franco Pinto J; Fillion A; Duchambon P; Bombard S; Granzhan A
Eur J Med Chem; 2022 Jan; 227():113909. PubMed ID: 34731767
[TBL] [Abstract][Full Text] [Related]
14. A multi-functional hypoxia/esterase dual stimulus responsive and hyaluronic acid-based nanomicelle for targeting delivery of chloroethylnitrosouea.
Li D; Ren T; Ge Y; Wang X; Sun G; Zhang N; Zhao L; Zhong R
J Nanobiotechnology; 2023 Aug; 21(1):291. PubMed ID: 37612719
[TBL] [Abstract][Full Text] [Related]
15. Reductive Activity and Mechanism of Hypoxia- Targeted AGT Inhibitors: An Experimental and Theoretical Investigation.
Xiao W; Sun G; Fan T; Liu J; Zhang N; Zhao L; Zhong R
Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31847200
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia-selective O6-alkylguanine-DNA alkyltransferase inhibitors: design, synthesis, and evaluation of 6-(benzyloxy)-2-(aryldiazenyl)-9H-purines as prodrugs of O6-benzylguanine.
Zhu R; Baumann RP; Penketh PG; Shyam K; Sartorelli AC
J Med Chem; 2013 Feb; 56(3):1355-9. PubMed ID: 23311288
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia and CD44 receptors dual-targeted nano-micelles with AGT-inhibitory activity for the targeting delivery of carmustine.
Li D; Wang X; Han K; Sun Y; Ren T; Sun G; Zhang N; Zhao L; Zhong R
Int J Biol Macromol; 2023 Aug; 246():125657. PubMed ID: 37399878
[TBL] [Abstract][Full Text] [Related]
18. Reductive activation of the prodrug 1,2-bis(methylsulfonyl)-1-(2-chloroethyl)-2-[[1-(4-nitrophenyl)ethoxy]carbonyl]hydrazine (KS119) selectively occurs in oxygen-deficient cells and overcomes O(6)-alkylguanine-DNA alkyltransferase mediated KS119 tumor cell resistance.
Baumann RP; Penketh PG; Ishiguro K; Shyam K; Zhu YL; Sartorelli AC
Biochem Pharmacol; 2010 Jun; 79(11):1553-61. PubMed ID: 20005211
[TBL] [Abstract][Full Text] [Related]
19. 1,2-Bis(methylsulfonyl)-1-(2-chloroethyl)-2-[(methylamino)carbonyl]hydrazine (VNP40101M): I. Direct inhibition of O6-alkylguanine-DNA alkyltransferase (AGT) by electrophilic species generated by decomposition.
Penketh PG; Shyam K; Baumann RP; Remack JS; Brent TP; Sartorelli AC
Cancer Chemother Pharmacol; 2004 Apr; 53(4):279-87. PubMed ID: 14704831
[TBL] [Abstract][Full Text] [Related]
20. Development and in vitro evaluation of carmustine delivery platform: A hypoxia-sensitive anti-drug resistant nanomicelle with BBB penetrating ability.
Li D; Ren T; Wang X; Xiao Z; Sun G; Zhang N; Zhao L; Zhong R
Biomed Pharmacother; 2023 Nov; 167():115631. PubMed ID: 37804814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
